Health Care/Hospital
Cytiva supports Clover Biopharmaceuticals to scale up the output of its vaccine candidate
* Clover aims to double its commercial manufacturing capacity in preparation for global Phase 2/3 trials * Cytiva provides FlexFactory™ bioprocessing upstream and downstream solutions for Clover to accelerate GMP facility development and shorten time to market SHANGHAI, Nov. 16, 2020 /PRNewsw...
Innovent Announces the Results of the Phase I Clinical Trial of IBI302, a First-in-class Ophthalmic Recombinant Human Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2020 American Academy of Ophthalmology
SAN FRANCISCO and SUZHOU, China, Nov. 16, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...
International Diabetes Federation calls for improved funding and training to help nurses tackle the global diabetes crisis
IDF marks World Diabetes Day and the International Year of the Nurse and Midwife by offering free accredited diabetes training BRUSSELS, Nov. 14, 2020 /PRNewswire/ -- This World Diabetes Day, the International Diabetes Federation (IDF) is calling for more nurses to be trained to help people livi...
The third CIIE concludes, $72.6 billion in intended deals for the coming year inked
SHANGHAI, Nov. 14, 2020 /PRNewswire/ -- Despite the global market uncertainties caused by the COVID-19 pandemic, the confidence and interest that foreign companies have in the Chinese market appear unchanged, with the value of tentative deals reached for one-year purchases of goods and services a...
CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
The CHMP recommended approval of ELZONRIS for the first line treatment of adult patients with BPDCN If approved by the European Commission, ELZONRIS will be the first approved treatment for patients with BPDCN, and the first approved CD123-targeted therapy, inEurope FLORENCE, Italy, Nov. 14...
FDI World Dental Federation: Study shows dramatic rise in antibiotics prescribed to dental patients in England during COVID-19 lockdown earlier this year
FDI World Dental Federation (FDI) releases new White Paper on antibiotic resistance to mark World Antimicrobial Awareness Week GENEVA and LONDON, Nov. 14, 2020 /PRNewswire/ -- One of the unintended consequences of the COVID-19 lockdowns inEngland earlier this year has been a 25 per cent increase...
The fourth CIIE begins taking stall reservations from exhibitors
SHANGHAI, Nov. 13, 2020 /PRNewswire/ -- Some exhibitors planning to attend the fourth China International Import Expo (CIIE) next year started to reserve their stalls onNov 8. This is the first time that the CIIE has offered such an option. Five dairy companies – Fonterra, Mille, Ausnutria, Yash...
AlpVision to offer free of charge security feature to protect COVID-19 relevant medicines against counterfeiting
VEVEY, Switzerland, Nov. 13, 2020 /PRNewswire/ -- On November 13th, 2020,
AlpVision is launching the "AlpVision COVID-19 Initiative" helping
pharmaceutical companies to protect COVID-19 relevant medicines against
counterfeiting.
Positive Results from RhoVac's Clinical Phase I/II Study published in Journal of ImmunoTherapy of Cancer
STOCKHOLM, Nov. 13, 2020 /PRNewswire/ -- RhoVac announces today, November 13, 2020, that the results of its clinical phase I/II study have been published in the Journal for ImmunoTherapy of Cancer (JITC). The scientifically reviewed article reports that the treatment with RhoVac's drug candidate ...
iONEBIO Inc. Deployment of FICS (Fast Infection Control System) at the International Airport of Paraguay
* iONEBIO iLAMP Novel-CoV19 Detection Kit is a high-speed laboratory assay intended as a groundbreaking aid in the diagnosis of SARS-CoV-2 infection. * This technologically advanced solution was developed in an attempt to serve as the gold standard in high-throughput high-accuracy testing, wit...
iONEBIO Inc. Deployment of FICS (Fast Infection Control System) at the International Airport of Paraguay
* iONEBIO iLAMP Novel-CoV19 Detection Kit is a high-speed laboratory assay intended as a groundbreaking aid in the diagnosis of SARS-CoV-2 infection. * This technologically advanced solution was developed in an attempt to serve as the gold standard in high-throughput high-accuracy testing, wit...
Indonesia's Government Sets Out to Rescue Microenterprises from the Pandemic Impact
* Nine million microenterprises have received the Banpres Produktif Usaha Mikro (Productive presidential aid for microenterprises) * Kredit Usaha Rakyat Super Mikro (Super-micro People's Business Credit) offered with an interest rate of 0% untilDecember 31 2020. JAKARTA, Indonesia, Nov. 17, 2...
Ascensia Diabetes Care Showcases The Crucial Support Nurses Provide People With Diabetes To Celebrate World Diabetes Day 2020
BASEL, Switzerland, Nov. 13, 2020 /PRNewswire/ -- Ascensia Diabetes Care, a leading global diabetes care company and maker of the CONTOUR® range of blood glucose monitoring systems, is tomorrow celebrating the crucial role that nurses play in helping people manage their diabetes, as part of World...
Secure World launches "COVID19-Guard", a non-contact, walkthrough-type security solution.
* 2020 Pandemic, Korea's Mask mandate is being recognized * The rising cases in Europe calls for adopting a Korean-style guideline and strategies * K-Quarantine has become a role model as COVID-19 spreads in the world * It is recommended to set the technology and strategy standards by benc...
Supported by 23 Ministries and Institutions, the Ministry of Tourism and Creative Economy Holds 3K Protocol Simulation for National Tourism Destinations
LABUAN BAJO, Indonesia, Nov. 13, 2020 /PRNewswire/ -- The Ministry of Tourism and Creative Economy / the Tourism and Creative Economy Agency (Kemenparekraf), supported by 23 ministries and institutions, held a simulation of the3K protocol (health, security, and safety) for national tourism destin...
Integrating Fitbit Wearable Devices into Diabetes Care Leads to Significant Improvements in Blood Glucose and HbA1C, Finds Health2Sync Clinical Study in Taiwan
* Wearing Fitbit devices with Health2Sync glucose control app clinically proven to help both users and healthcare providers to control and better manage the symptoms of Type 2 diabetes * Results from the study in Taiwan revealed an improvement in patients' health conditions, with participants...
Integrating Fitbit Wearable Devices into Diabetes Care Leads to Significant Improvements in Blood Glucose and HbA1C, Finds Health2Sync Clinical Study in Taiwan
* Wearing Fitbit devices with Health2Sync glucose control app clinically proven to help both users and healthcare providers to control and better manage the symptoms of Type 2 diabetes * Results from the study in Taiwan revealed an improvement in patients' health conditions, with participants...
Integrating Fitbit Wearable Devices into Diabetes Care Leads to Significant Improvements in Blood Glucose and HbA1C, Finds Health2Sync Clinical Study in Taiwan
* Wearing Fitbit devices with Health2Sync glucose control app clinically proven to help both users and healthcare providers to control and better manage the symptoms of Type 2 diabetes * Results from the study in Taiwan revealed an improvement in patients' health conditions, with participants...
Integrating Fitbit Wearable Devices into Diabetes Care Leads to Significant Improvements in Blood Glucose and HbA1C, Finds Health2Sync Clinical Study in Taiwan
* Wearing Fitbit devices with Health2Sync glucose control app clinically proven to help both users and healthcare providers to control and better manage the symptoms of Type 2 diabetes * Results from the study in Taiwan revealed an improvement in patients' health conditions, with participants...
Integrating Fitbit Wearable Devices into Diabetes Care Leads to Significant Improvements in Blood Glucose and HbA1C, Finds Health2Sync Clinical Study in Taiwan
* Wearing Fitbit devices with Health2Sync glucose control app clinically proven to help both users and healthcare providers to control and better manage the symptoms of Type 2 diabetes * Results from the study in Taiwan revealed an improvement in patients' health conditions, with participants...
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 291 media titles]
2024-04-30 10:11Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 249 media titles]
2024-04-30 15:13New International Land-Sea Trade Corridor achieves rapid development
[Picked up by 246 media titles]
2024-04-28 10:24